Variants in DENND1A and LHCGR are associated with endometrioid adenocarcinoma

Gynecologic Oncology

Volumn 127, Issue 2, 2012, Pages 403-405

  Wang, Zhenyan ^a,b   Li, Tao ^a   Zhang, Wei ^a   You, Li ^a,c   Zhao, Yueran ^a,c   Xia, Mingdi ^a   Zhao, Han ^a,c   Chen, Zi Jiang ^a,c  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Association; Endometrial carcinoma; Endometrioid adenocarcinoma; Polycystic ovary syndrome

Indexed keywords

DENND1A PROTEIN; LHCGR PROTEIN; THADA PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

AGE; ARTICLE; BODY MASS; CHINESE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

AGE FACTORS; BODY MASS INDEX; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; CHINA; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPING TECHNIQUES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, LH; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 84867404664     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.08.007     Document Type: Article

References (14)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. K. Niwa, A. Imai, M. Hashimoto, Y. Yokoyama, H. Mori, and Y. Matsuda A case-control study of uterine endometrial cancer of pre- and post-menopausal women Oncol Rep 7 2000 89 93
3. A.P. Cheung Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome Obstet Gynecol 98 2001 325 331
4. M. Gambacciani, P. Monteleone, A. Sacco, and A.R. Genazzani Hormone replacement therapy and endometrial, ovarian and colorectal cancer Best Pract Res Clin Endocrinol Metab 17 2003 139 147
5. P. Hardiman, O.C. Pillay, and W. Atiomo Polycystic ovary syndrome and endometrial carcinoma Lancet 361 2003 1810 1812
6. Z.J. Chen, H. Zhao, L. He, Y. Shi, Y. Qin, and Y. Shi Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3 Nat Genet 43 2010 55 59
7. H. Zhao, X. Xu, X. Xing, J. Wang, L. He, and Y. Shi Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3 Hum Reprod 27 2012 294 298
8. H. Speert Carcinoma of the endometrium in young women Surg Gynecol Obstet 88 1949 332 336
9. P.D. Allaire, B. Ritter, S. Thomas, J.L. Burman, A.Y. Denisov, and V. Legendre-Guillemin Connecdenn, a novel DENN domain-containing protein of neuronal clathrin-coated vesicles functioning in synaptic vesicle endocytosis J Neurosci 26 2006 13202 13212
10. P.D. Allaire, A.L. Marat, C. Dall'armi, G. Di Paolo, P.S. McPherson, and B. Ritter Mol Cell 37 2010 370 382
11. M. Filicori, A.T. Fazleabas, I. Huhtaniemi, P. Licht, C.V. Rao, and J. Tesarik Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility Fertil Steril 84 2005 275 284
12. N.A. Rahman, and C.V. Rao Recent progress in luteinizing hormone/human chorionic gonadotrophin hormone research Mol Hum Reprod 15 2009 703 711
13. J. Lin, Z.M. Lei, S. Lojun, C.V. Rao, P.G. Satyaswaroop, and T.G. Day Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas J Clin Endocrinol Metab 79 1994 1483 1491
14. S. Dabizzi, I. Noci, P. Borri, E. Borrani, M. Giachi, and M. Balzi Luteinizing hormone increases human endometrial cancer cells invasiveness through activation of protein kinase A Cancer Res 63 2003 4281 4286